Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project

Introduction Neoadjuvant systemic anticancer therapy (neoSACT) is increasingly used in the treatment of early breast cancer. Response to therapy is prognostic and allows locoregional and adjuvant systemic treatments to be tailored to minimise morbidity and optimise oncological outcomes and quality o...

Full description

Bibliographic Details
Main Authors: Hiroji Iwata, Kerry Avery, Shelley Potter, Katherine Cowan, Andrew Spillane, Stuart McIntosh, David Dodwell, Alastair M Thompson, Rosina Ahmed, Mairead MacKenzie, Jana de Boniface, Peter Dubsky, Gustavo Werutsky, Sanjoy Chatterjee, Michael Jiang, Han-Byoel Lee, Fiorita Poulakaki, Andrea L Richardson, Karla Sepulveda, Jean L Wright, Nicholas Zdenkowski
Format: Article
Language:English
Published: BMJ Publishing Group 2024-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/4/e084488.full